about
Tubulin-interactive natural products as anticancer agentsStabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Microtubule-binding agents: a dynamic field of cancer therapeutics.Ixabepilone for the treatment of solid tumors: a review of clinical dataA myxobacterium strain Sorangium cellulosum AHB125 producing epothilone B and other anticancer substances.Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.Development of new cancer therapeutic agents targeting mitosis.Chemotherapy and targeted molecular therapies for brain metastases.Investigational agents against platinum-resistant ovarian cancer.Ixabepilone for the treatment of taxane-refractory breast cancer.Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.Stilbene 5c, a microtubule poison with vascular disrupting properties that induces multiple modes of growth arrest and cell death.Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.Diversity of epothilone producers among Sorangium strains in producer-positive soil habitats.A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group studyMicrotubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.Optimal treatment for relapsing ovarian cancer.Substrate specificity of the acyl transferase domains of EpoC from the epothilone polyketide synthase.The binding mode of side chain- and C3-modified epothilones to tubulin.Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model.
P2860
Q24650163-548CB523-B57D-4762-A889-9A4AC91AA57DQ26781365-CC9441F1-C8B6-4813-A507-1D7F467625CEQ27690249-74A687C3-C803-4501-B2D6-0DB2215490E4Q28271570-6057087C-1ABD-4446-BBDF-F57811E90C07Q33310027-F188E73D-EC54-49C9-A51F-B56E0BD39F20Q34788890-147B95D9-1C92-4B27-BD07-12922C053E99Q35884220-122271E9-D7E5-4AC9-92B6-1A7720DEE3ECQ35997562-39650586-C28F-4BE9-9B80-AD8163687F6DQ36623076-5BD73156-83E7-4ABA-9AB2-442A12887490Q36641504-3F861D7C-6A2C-4ED3-A6D6-F7FBEC18E387Q36736349-B5654295-C884-45D4-AFD6-7243766463FDQ37179381-E01F1380-4630-4F2D-B093-E83D10D58248Q37236419-9728D1D2-EF41-42FC-B946-F040C7925573Q37373970-6FA52D46-A3D8-4E8F-BC3D-DCECF2FAE378Q37607909-CA040AC2-78CC-4D17-AF17-9FEFB906FA52Q37608620-DD6C4173-B634-4F5F-B99D-1ED6ECE1D745Q37716223-F7010342-3C00-4661-814D-0AF80529130AQ37722656-505D8CA5-0398-4EF4-B88E-E316500FFD44Q37799929-A9E30C82-147B-403A-AFB4-28600CF1DC7DQ38438983-1C7214AD-A19D-4465-B743-699F72999E78Q39708874-E7739167-67FC-4574-873F-4438AA9A1CCBQ43702348-ABBF101B-E0ED-47C1-8B27-B8219ACD8B63
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Epothilones in the treatment of cancer.
@ast
Epothilones in the treatment of cancer.
@en
type
label
Epothilones in the treatment of cancer.
@ast
Epothilones in the treatment of cancer.
@en
prefLabel
Epothilones in the treatment of cancer.
@ast
Epothilones in the treatment of cancer.
@en
P2860
P1476
Epothilones in the treatment of cancer.
@en
P2093
James M G Larkin
Stanley B Kaye
P2860
P304
P356
10.1517/13543784.15.6.691
P407
P577
2006-06-01T00:00:00Z